Pfizer (PFE) PT Lowered to $44 at Morgan Stanley
Get Alerts PFE Hot Sheet
Price: $26.80 --0%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on Pfizer (NYSE: PFE) to $44.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Veritone (VERI) PT Lowered to $5 at Needham
- Citi raises EquipmentShare price target to $22, keeps Neutral
- Braze Inc (BRZE) PT Raised to $35 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share